• En
  • De
  • Fr
  • It
Screen4Care logo
  • Le projet
    • Qu’est-ce que Screen4Care ?
    • Structure
    • Les centres d’intérêt
    • Financement
    • Timeline
  • Personnes atteintes de maladies rares
    • Implication d’EURORDIS
    • Comité consultatif des patients
  • Research et Innovation
    • Double approche
    • Publications
    • Conseil scientifique consultatif
  • Rencontrer les partenaires
    • Partenaires de Screen4Care
    • Voix de Screen4Care
  • News & Events
  • Contact
  • World Orphan Drug Congress USA 2022

    11 Jul 2022 — 13 Jul 2022
    Hynes Center, Boston, MA (USA)

    The World’s Most Important Orphan Drug and Rare Disease Event

    We are pleased to announce that our Project Lead Nicolas Garnier and our key partner EURORDIS are presenting Screen4Care at this conference on 13 July.

  • 11th European Conference on Rare Diseases & Orphan Products

    27 Jun 2022 — 01 Jul 2022
    Online, Virtual
  • Rare Disease Day 2022

    28 Feb 2022
    Worldwide
  • Imprint
  • Privacy
  • Intranet
  • Contact
EU
IMI
EFPIA

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101034427.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.